A novel presenilin 1 mutation associated with Pick's disease but not β-amyloid plaques

被引:156
作者
Dermaut, B
Kumar-Singh, S
Engelborghs, S
Theuns, J
Rademakers, R
Sacrens, J
Pickut, BA
Peeters, K
van den Broeck, M
Vennekens, K
Claes, S
Cruts, M
Cras, P
Martin, JJ
Van Broeckhoven, C
De Deyn, PP
机构
[1] Univ Instelling Antwerp VIB, Dept Mol Genet V1B8, B-2610 Antwerp, Belgium
[2] Univ Instelling Antwerp, Born Bunge Fdn, Dept Biomed Sci, Lab Neurochem & Behav, B-2610 Antwerp, Belgium
[3] Middelheim Hosp, Dept Neurol, Antwerp, Belgium
[4] Middelheim Hosp, Memory Clin, Antwerp, Belgium
[5] Univ Instelling Antwerp, Born Bunge Fdn, Neurobiol Lab, B-2610 Antwerp, Belgium
[6] Univ Instelling Antwerp, Born Bunge Fdn, Neuropathol Lab, B-2610 Antwerp, Belgium
关键词
D O I
10.1002/ana.20083
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Familial forms of frontotemporal dementia (FTD) with tauopathy are mostly caused by mutations in the gene encoding the microtubule-associated protein tau (MAPT). However, rare forms of familial tauopathy without MAPT mutations have been reported, suggesting other tauopathy-related genetic defects. Interestingly, two presenilin I (PSI) mutations (Leu113Pro and insArg352) recently have been associated with familial FTD albeit without neuropathological confirmation. We report here a novel PSI mutation in a patient with Pick-type tauopathy in the absence of extracellular beta-amyloid deposits. The mutation is predicted to substitute Gly-->Val at codon position 183 (Gly183Val) and to affect the splice signal at the junction of the sixth exon and intron. Further clinical-genetic investigation showed a positive family history of FTD-like dementia and suggested that Gly183Val is associated with a phenotypically heterogeneous neurodegenerative disorder. Our results suggest PSI as a candidate gene for Pick-type tauopathy without MAPT mutations.
引用
收藏
页码:617 / 626
页数:10
相关论文
共 40 条
[1]   A presenilin 1 mutation associated with familial frontotemporal dementia inhibits γ-secretase cleavage of APP and notch [J].
Amtul, Z ;
Lewis, PA ;
Piper, S ;
Crook, R ;
Baker, M ;
Findlay, K ;
Singleton, A ;
Hogg, M ;
Younkin, L ;
Younkin, SG ;
Hardy, J ;
Hutton, M ;
Boeve, BF ;
Tang-Wai, D ;
Golde, TE .
NEUROBIOLOGY OF DISEASE, 2002, 9 (02) :269-273
[2]   Familial Alzheimer's disease-linked presenilin 1 variants elevate A beta 1-42/1-40 ratio in vitro and in vivo [J].
Borchelt, DR ;
Thinakaran, G ;
Eckman, CB ;
Lee, MK ;
Davenport, F ;
Ratovitsky, T ;
Prada, CM ;
Kim, G ;
Seekins, S ;
Yager, D ;
Slunt, HH ;
Wang, R ;
Seeger, M ;
Levey, AI ;
Gandy, SE ;
Copeland, NG ;
Jenkins, NA ;
Price, DL ;
Younkin, SG .
NEURON, 1996, 17 (05) :1005-1013
[3]  
BRUN A, 1994, J NEUROL NEUROSUR PS, V57, P416
[4]   Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid beta-protein in both transfected cells and transgenic mice [J].
Citron, M ;
Westaway, D ;
Xia, WM ;
Carlson, G ;
Diehl, T ;
Levesque, G ;
JohnsonWood, K ;
Lee, M ;
Seubert, P ;
Davis, A ;
Kholodenko, D ;
Motter, R ;
Sherrington, R ;
Perry, B ;
Yao, H ;
Strome, R ;
Lieberburg, I ;
Rommens, J ;
Kim, S ;
Schenk, D ;
Fraser, P ;
Hyslop, PS ;
Selkoe, DJ .
NATURE MEDICINE, 1997, 3 (01) :67-72
[5]  
Cox RT, 2000, GENETICS, V155, P1725
[6]   MOLECULAR-GENETIC ANALYSIS OF FAMILIAL EARLY-ONSET ALZHEIMERS-DISEASE LINKED TO CHROMOSOME 14Q24.3 [J].
CRUTS, M ;
BACKHOVENS, H ;
WANG, SY ;
VANGASSEN, G ;
THEUNS, J ;
DEJONGHE, C ;
WEHNERT, A ;
DEVOECHT, J ;
DEWINTER, G ;
CRAS, P ;
BRUYLAND, M ;
DATSON, N ;
WEISSENBACH, J ;
DENDUNNEN, JT ;
MARTIN, JJ ;
HENDRIKS, L ;
Van Broeckhoven, C .
HUMAN MOLECULAR GENETICS, 1995, 4 (12) :2363-2371
[7]   Estimation of the genetic contribution of presenilin-1 and -2 mutations in a population based study of presenile Alzheimer disease [J].
Cruts, M ;
van Duijn, CM ;
Backhovens, H ;
Van den Broeck, M ;
Wehnert, A ;
Serneels, S ;
Sherrington, R ;
Hutton, M ;
Hardy, J ;
St George-Hyslop, PH ;
Hofman, A ;
Van Broeckhoven, C .
HUMAN MOLECULAR GENETICS, 1998, 7 (01) :43-51
[8]   Evidence that Aβ42 plasma levels in presenilin-1 mutation carriers do not allow for prediction of their clinical phenotype [J].
De Jonghe, C ;
Cras, P ;
Vanderstichele, H ;
Cruts, M ;
Vanderhoeven, I ;
Smouts, I ;
Vanmechelen, E ;
Martin, JJ ;
Hendriks, L ;
Van Broeckhoven, C .
NEUROBIOLOGY OF DISEASE, 1999, 6 (04) :280-287
[9]   Flemish and Dutch mutations in amyloid β precursor protein have different effects on amyloid β secretion [J].
De Jonghe, C ;
Zehr, C ;
Yager, D ;
Prada, CM ;
Younkin, S ;
Hendriks, L ;
Van Broeckhoven, C ;
Eckman, CB .
NEUROBIOLOGY OF DISEASE, 1998, 5 (04) :281-286
[10]   Aph-1, Pen-2, and nicastrin with presenilin generate an active γ-secretase complex [J].
De Strooper, B .
NEURON, 2003, 38 (01) :9-12